Driven by precision medicine and digital technologies, the brachytherapy needle industry has moved beyond basic device manufacturing and advances rapidly toward intelligence, personalization and minimal invasiveness. Innovation no longer merely focuses on physical properties of needle bodies, but emphasizes deep integration with cutting-edge technologies to reshape cancer treatment paradigms.

The combination of personalized customization and 3D printing stands out as one of the most promising trends. Conventional straight needles fail to handle complicated anatomical conditions, such as recurrent tumors adjacent to intestines or major blood vessels, and clinical cases requiring angled needle placement. Currently, 3D printing fabricates customized applicators and curved needle guides perfectly matching individual anatomical structures based on patient CT and MRI scans.

Pioneering studies have realized direct printing of personalized curved interstitial needles with designated curvatures. Applied for recurrent cervical cancer involving the uterine fundus, such devices deliver precise treatment to distant tumors via natural orifices without percutaneous puncture, effectively alleviating patient discomfort and lowering complication risks. This marks a fundamental shift from patients adapting to standard instruments to customized devices fitting individual physiological features.

Artificial intelligence and automation are deeply applied throughout the whole treatment workflow. In preoperative planning, AI algorithms rapidly analyze massive imaging data, automatically delineate tumor targets and organs at risk, and optimize needle trajectories and dose distribution. Manual planning taking several hours can be shortened into just minutes.

Intraoperatively, robot-assisted puncture systems have been introduced into clinical practice. Robotic arms implant multiple treatment needles steadily and accurately following AI-generated paths, achieving higher precision and reproducibility than manual manipulation. The technology is particularly suitable for prostate cancer demanding dense parallel needle arrangement. It reduces operational difficulty and learning difficulty for physicians, and generates more standardized and predictable therapeutic outcomes.

Breakthroughs in image guidance transform blind puncture into real-time navigation. Ultrasound guidance has become a standard technique for prostate seed implantation, while MRI-guided brachytherapy emerges as an advanced mainstream modality. Featuring superior soft tissue resolution, MRI clearly visualizes positional relations among tumors, needles and surrounding healthy organs during surgery, enabling genuine real-time visualization and dynamic dose adjustment. Accordingly, brachytherapy needles are required to possess excellent MRI compatibility, making titanium alloy materials and artifact-free designs increasingly essential. Multimodal navigation combining ultrasound, MRI and optical positioning will further elevate puncture accuracy in the future.

Advances in material science pave the way for revolutionary biodegradable needles. Traditional afterloading and implantation needles have to be removed after treatment. Novel needles made of polylactic acid and other degradable materials can be gradually absorbed safely inside human bodies after completing radiation delivery. The trauma-free procedure eliminates needle extraction, simplifies clinical workflows and reduces infection risks, presenting great advantages for deep-seated lesions and sites inaccessible to secondary puncture.

Therapeutic modalities are also continuously expanded. Synergies between brachytherapy and immunotherapy are actively explored. High-dose radiation induces immunogenic cell death and releases tumor-associated antigens. Combined application with immune checkpoint inhibitors may trigger abscopal effects and activate systemic anti-tumor immune responses, requiring flexible needle placement strategies adapted to combination therapy.

These emerging trends bring both challenges and opportunities for manufacturers represented by Manners Technology. Cross-industry collaboration with clinical specialists, algorithm developers and robotic enterprises is necessary to understand and fulfill sophisticated clinical demands. Meanwhile, manufacturers can upgrade from component suppliers to core providers of intelligent surgical solutions. Typical examples include producing smart needles embedded with optical fiber sensors, and supplying medical-grade metal powder and post-printing processing techniques for 3D curved needles. In the future, brachytherapy needles will evolve from standalone consumables into intelligent terminals integrated into a comprehensive therapeutic ecosystem consisting of intelligent planning, robotic navigation, real-time imaging and biological feedback.